Luxi Ye

Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC

Qianqian Zhao, Gang Chen, Luxi Ye et al. · Radiation Oncology · 2019 · 52 citations · Full text

Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation Therapy

Tiantian Guo, Jianjiao Ni, Xi Yang et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 50 citations

Radiation Therapy, Medicine, Recurrence Analysis +5

Clinical Value of Upfront Cranial Radiation Therapy in Osimertinib-Treated Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer With Brain Metastases

Fan Yu, Jianjiao Ni, Wanqin Zeng et al. · International Journal of Radiation Oncology*Biology*Physics · 2021 · 50 citations

Neuro-oncology, Radiation Medicine, Radiation Therapy +9

Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitors

Yue Zhou, Bo Wang, Jinghan Qu et al. · Lung Cancer · 2020 · 29 citations

Neuro-oncology, Survival Outcomes, Medicine +7

Patterns and risks of postoperative recurrence in completely resected EGFR-mutant non-small cell lung cancer: prognostic significance of routine immunohistochemical markers

Jianjiao Ni, Tiantian Guo, Yuan Li et al. · Translational Lung Cancer Research · 2019 · 23 citations · Full text